The investment world still doubts that B-cell tech is working...

The investment world still doubts that B-cell tech is working better than anything else. But more and more scientists see the huge potential, hence the impressive line up at 
SAB. If the Israelis followed IMU's approach and had success in mice too then it validates the tech even more. No worries for IMU regarding competition as these guys are years behind the trials. To get the investment cowboys interested we need main stream media reporting the superiority over what is currently available. Scientific paper publication won't do it, unfortunately only sensationalised headlines will do.

Let's start the B-cell mania.

GLTA